+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sodium Oxybate Oral Medications Market - Global Forecast 2026-2032- Product Image
Sodium Oxybate Oral Medications Market - Global Forecast 2026-2032- Product Image
New

Sodium Oxybate Oral Medications Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 190 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6084840
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The sodium oxybate oral medications market presents a complex landscape driven by regulatory demands, payer pressures, and evolving patient priorities. Senior decision-makers operating in this environment must consider access barriers, operational efficiency, and differentiated support strategies when building for growth and resilience.

Market Snapshot: Sodium Oxybate Oral Medications Market

The sodium oxybate oral medications market advanced from USD 1.70 billion in 2025 to USD 1.84 billion in 2026, continuing to expand at a compound annual growth rate (CAGR) of 7.80%. Projections estimate the market will reach USD 2.88 billion by 2032. This upward trajectory reflects steady global demand for therapies that combine clinical effectiveness with focus on operational compliance, particularly important for controlled substance categories where regulatory overhead and reliability are critical to product adoption.

Scope & Segmentation

  • Formulation Types: Encompasses various oral dosages, each influencing patient adherence, dose scheduling, and monitoring needs.
  • Indications: Includes applications for sustained management of sleep disorders and other conditions necessitating ongoing symptom control.
  • Distribution Channels: Covers specialty pharmacies, direct-to-provider models, and hub services, each impacting delivery efficiency and access timelines.
  • Patient Segments: Analyzes groups by age, caregiver involvement, regimen complexity, and persistence requirements to highlight drivers of long-term use.
  • Regional Coverage: Compares North America, Europe, Middle East & Africa, and Asia-Pacific, illustrating differences in access infrastructure, regulatory approach, and reimbursement landscapes.
  • Technological Integration: Reviews digital workflow adoption, automated prior authorization, and patient-engagement platforms supporting pharmacovigilance and operational streamlining.

Key Takeaways: Strategic Insights for Senior Leaders

  • Market leadership depends on combining targeted formulation design with process efficiency and comprehensive patient support tools, moving beyond clinical benefit alone.
  • Payer evaluation has intensified; companies are embedding adherence technologies, risk mitigation plans, and prior authorization support to meet growing access requirements.
  • Working with specialized pharmacy and distribution partners ensures timely delivery, regulatory compliance, and smoother navigation of benefit verification and logistics for controlled substances.
  • Regional variance in governance and care infrastructure requires customized adoption strategies and operational alignment to support long-term product utilization.
  • Understanding patient profile nuances, including caregiver dynamics and convenience of prescription regimens, remains key to optimizing therapy initiation and adherence across populations.

Tariff Impact: Navigating Global Supply Chain Volatility

Anticipated changes in trade policy, such as projected United States tariffs in 2025, may increase overall supply chain vulnerability for sodium oxybate oral medications. Tariffs targeting chemical precursors, packaging, or specialty equipment can result in higher procurement expenses and necessitate adjustments to supplier selection and contingency planning. The shift toward dual-sourcing or enhancing domestic manufacturing can increase complexity, especially for controlled substances where strict compliance and chain-of-custody trackability are crucial. Any input cost growth is likely to impact downstream payer negotiations and compress operational margins, making scenario planning and proactive risk strategies increasingly vital.

Methodology & Data Sources

This sodium oxybate oral medications market analysis is based on a mix of secondary data review, regulatory assessment, and direct interviews with clinicians, specialty pharmacy experts, payers, and supply chain professionals. Conclusions have been validated across stakeholder types and reflect region- and channel-specific insights to support actionable and credible analysis.

Sodium Oxybate Oral Medications Market: Why This Report Matters

  • Enables commercial leaders to identify operational, regulatory, and market access challenges that influence uptake beyond conventional clinical effectiveness.
  • Delivers frameworks to align product and access strategies with evolving payer expectations and infrastructure realities across key global regions.
  • Prepares organizations for tariff-related cost changes and supply continuity risks, supporting pro-active mitigation and long-term planning.

Conclusion

With regulatory scrutiny increasing and payer demands evolving, success in the sodium oxybate oral medications market depends on a unified approach across product design, access, and compliance. Senior leaders who drive operational integration stand to enhance positioning and sustainable market presence.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Sodium Oxybate Oral Medications Market, by Indication
8.1. Idiopathic Hypersomnia
8.2. Narcolepsy
8.2.1. Type One Narcolepsy
8.2.2. Type Two Narcolepsy
8.3. Off-Label Use
8.3.1. Kleine Levin Syndrome
9. Sodium Oxybate Oral Medications Market, by Strength
9.1. Four Point Five Gram
9.2. Nine Gram
9.3. Seven Point Five Gram
9.4. Six Gram
10. Sodium Oxybate Oral Medications Market, by Distribution Channel
10.1. Hospital Pharmacies
10.2. Online Pharmacies
10.3. Retail Pharmacies
10.4. Specialty Pharmacies
11. Sodium Oxybate Oral Medications Market, by Dosage Form
11.1. Liquid
11.2. Powder
12. Sodium Oxybate Oral Medications Market, by End User
12.1. Home Care
12.2. Hospitals
12.3. Specialty Clinics
13. Sodium Oxybate Oral Medications Market, by Packaging Type
13.1. Multi Dose
13.2. Single Dose
14. Sodium Oxybate Oral Medications Market, by Patient Age Group
14.1. Adults
14.2. Pediatrics
15. Sodium Oxybate Oral Medications Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific
16. Sodium Oxybate Oral Medications Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Sodium Oxybate Oral Medications Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. United States Sodium Oxybate Oral Medications Market
19. China Sodium Oxybate Oral Medications Market
20. Competitive Landscape
20.1. Market Concentration Analysis, 2025
20.1.1. Concentration Ratio (CR)
20.1.2. Herfindahl Hirschman Index (HHI)
20.2. Recent Developments & Impact Analysis, 2025
20.3. Product Portfolio Analysis, 2025
20.4. Benchmarking Analysis, 2025
20.5. Alembic Pharmaceuticals Limited
20.6. Amneal Pharmaceuticals, Inc.
20.7. Aurobindo Pharma Limited
20.8. Cipla Limited
20.9. Dr. Reddy's Laboratories Ltd.
20.10. Glenmark Pharmaceuticals Ltd.
20.11. Hetero Labs Limited
20.12. Hikma Pharmaceuticals PLC
20.13. Jazz Pharmaceuticals plc
20.14. Lannett Company, Inc.
20.15. Lupin Limited
20.16. Macleods Pharmaceuticals Ltd.
20.17. Mylan N.V.
20.18. Natco Pharma Limited
20.19. Novartis AG
20.20. Strides Pharma Science Limited
20.21. Sun Pharmaceutical Industries Ltd.
20.22. Teva Pharmaceutical Industries Ltd.
20.23. Torrent Pharmaceuticals Ltd.
20.24. Zydus Lifesciences Limited
List of Figures
FIGURE 1. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 15. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY IDIOPATHIC HYPERSOMNIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY IDIOPATHIC HYPERSOMNIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY IDIOPATHIC HYPERSOMNIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY TYPE ONE NARCOLEPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY TYPE ONE NARCOLEPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY TYPE ONE NARCOLEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY TYPE TWO NARCOLEPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY TYPE TWO NARCOLEPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY TYPE TWO NARCOLEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY KLEINE LEVIN SYNDROME, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY KLEINE LEVIN SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY KLEINE LEVIN SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY FOUR POINT FIVE GRAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY FOUR POINT FIVE GRAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY FOUR POINT FIVE GRAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NINE GRAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NINE GRAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NINE GRAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SEVEN POINT FIVE GRAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SEVEN POINT FIVE GRAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SEVEN POINT FIVE GRAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SIX GRAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SIX GRAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SIX GRAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SPECIALTY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SPECIALTY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY MULTI DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY MULTI DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SINGLE DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SINGLE DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 121. EUROPE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. EUROPE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 123. EUROPE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2032 (USD MILLION)
TABLE 124. EUROPE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2032 (USD MILLION)
TABLE 125. EUROPE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 126. EUROPE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 127. EUROPE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 128. EUROPE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. EUROPE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 130. EUROPE SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 141. AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 143. AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2032 (USD MILLION)
TABLE 144. AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2032 (USD MILLION)
TABLE 145. AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 146. AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 147. AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 148. AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 150. AFRICA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. ASEAN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. ASEAN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 164. ASEAN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2032 (USD MILLION)
TABLE 165. ASEAN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2032 (USD MILLION)
TABLE 166. ASEAN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 167. ASEAN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 168. ASEAN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 169. ASEAN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. ASEAN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 171. ASEAN SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 172. GCC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. GCC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 174. GCC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2032 (USD MILLION)
TABLE 175. GCC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2032 (USD MILLION)
TABLE 176. GCC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 177. GCC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 178. GCC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 179. GCC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. GCC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 181. GCC SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 192. BRICS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. BRICS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 194. BRICS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2032 (USD MILLION)
TABLE 195. BRICS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2032 (USD MILLION)
TABLE 196. BRICS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 197. BRICS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 198. BRICS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 199. BRICS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. BRICS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 201. BRICS SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 202. G7 SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 203. G7 SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 204. G7 SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2032 (USD MILLION)
TABLE 205. G7 SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2032 (USD MILLION)
TABLE 206. G7 SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 207. G7 SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 208. G7 SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 209. G7 SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 210. G7 SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 211. G7 SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 212. NATO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. NATO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 214. NATO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2032 (USD MILLION)
TABLE 215. NATO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2032 (USD MILLION)
TABLE 216. NATO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 217. NATO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 218. NATO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 219. NATO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 220. NATO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 221. NATO SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 222. GLOBAL SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 233. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 234. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 235. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY NARCOLEPSY, 2018-2032 (USD MILLION)
TABLE 236. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY OFF-LABEL USE, 2018-2032 (USD MILLION)
TABLE 237. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 238. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 239. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 240. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 241. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
TABLE 242. CHINA SODIUM OXYBATE ORAL MEDICATIONS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Sodium Oxybate Oral Medications market report include:
  • Alembic Pharmaceuticals Limited
  • Amneal Pharmaceuticals, Inc.
  • Aurobindo Pharma Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Hetero Labs Limited
  • Hikma Pharmaceuticals PLC
  • Jazz Pharmaceuticals plc
  • Lannett Company, Inc.
  • Lupin Limited
  • Macleods Pharmaceuticals Ltd.
  • Mylan N.V.
  • Natco Pharma Limited
  • Novartis AG
  • Strides Pharma Science Limited
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Zydus Lifesciences Limited

Table Information

Report AttributeDetails
No. of Pages190
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.84 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.88 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Pharmaceuticals - Enterprise ICT - Product Image

Pharmaceuticals - Enterprise ICT

  • Report
  • 54 Pages
  • Global
From
U.S. Pharmaceutical Market, By Region, By Competition, Opportunities & Forecast, 2020-2030F - Product Image

U.S. Pharmaceutical Market, By Region, By Competition, Opportunities & Forecast, 2020-2030F

  • Report
  • 85 Pages
  • United States
From
Pharmaceuticals North America (NAFTA) Industry Guide 2019-2028 - Product Image

Pharmaceuticals North America (NAFTA) Industry Guide 2019-2028

  • Report
  • 286 Pages
  • North America
From
Pharmaceutical Sterile Fill-Finish - Global Strategic Business Report - Product Image

Pharmaceutical Sterile Fill-Finish - Global Strategic Business Report

  • Report
  • 291 Pages
  • Global
From
Narcolepsy Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Narcolepsy Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.